Fund Close at >$250 million (>£200 million) for unique deep tech, deep science investment model
Ahren today announced that it has completed the close of its fund, Ahren LP, in excess of $250 million (£200 million).
Ahren’s model is characterised by:
- Its Founding Science Partner model and multidisciplinary approach – believing future breakthroughs will occur at the intersection of its domains;
- Helping build companies, as well as invest – to support successful outcomes;
- Being both visionary and commercial – its investments must be both cutting edge technology and have the potential to be highly profitable;
- Its exclusive strategic and corporate LPs – these LPs are Ahren’s valued partners, which can also provide expertise, access and customers to its entrepreneurs.
Alice Newcombe-Ellis, Founding Partner, Ahren, said: “We feel privileged to have an LP base of exceptional individuals and institutions sharing Ahren’s vision and values. We consider this our valued ‘family’ of thought-leaders.”
“We now focus our attention on actively supporting entrepreneurs to achieve their ambitions. We are very selective in identifying outstanding opportunities, but once we invest, we are deeply committed to helping ensure their success.”
Sir Shankar Balasubramanian, Founding Science Partner, Ahren, and principal inventor of the world’s leading DNA sequencing technology, said: “The best entrepreneurs look to raise capital from groups they trust, respect and want to be like; and groups that can have a differentiated impact on their success. We aim to inspire, create, nurture and build great enterprises.”
Lord Martin Rees, Founding Science Partner, Ahren & Astronomer Royal said:
“Our founding and limited partners have long-term investment horizons and together take an active role in shaping the future, supporting breakthrough technologies that will offer improvements in human lives, and a more sustainable world.”
Ahren Innovation Capital LLP is authorised and regulated by the UK Financial Services Authority. Ahren was founded by Alice Newcombe-Ellis and through Ahren LP and its affiliates, is an investor in deep tech and deep science.
For more information, contact email@example.com
This press release does not constitute an offer of interests in any Ahren fund. Any offer of an Ahren fund will be made through separate offering documents and in accordance with applicable laws and regulations. This press release may contain forward looking statements. These statements include, but are not limited to, discussions related to Ahren’s expectations regarding the performance of its business, its liquidity and capital resources and the other statements contained herein. These forward-looking statements are based on management’s beliefs, as well as assumptions made by, and information currently available to, management. When used in this press release, the words “believe,” “anticipate,” “estimate,” “expect,” “intend” and similar expressions are intended to identify forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. These statements are subject to certain risks, uncertainties and assumptions. Ahren gives no undertaking or assumes any obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law.
Ahren believes that selected case studies should be considered as a reflection of Ahren’s investment process, and references to these particular portfolio companies should not be considered as recommendations of any particular security, investment or portfolio company. The information provided about these portfolio companies is intended to be illustrative, and is not intended to be used as an indication of the current or future performance of the portfolio companies of the fund that Ahren manages.